Lauren Wetzler
Publications by Year
Research Areas
Eosinophilic Disorders and Syndromes, Eosinophilic Esophagitis, Urticaria and Related Conditions, Asthma and respiratory diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Most-Cited Works
- → Benralizumab for PDGFRA -Negative Hypereosinophilic Syndrome(2019)209 cited
- → Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome(2018)91 cited
- → Natural History of Treated Subarachnoid Neurocysticercosis(2019)78 cited
- → Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes(2018)63 cited
- → Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease(2022)60 cited
- → Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis(2020)55 cited
- → Successful pregnancy in the setting of eosinophil depletion by benralizumab(2020)36 cited
- → An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes(2022)33 cited
- → Urine eosinophil‐derived neurotoxin: A potential marker of activity in select eosinophilic disorders(2022)20 cited
- → Dupilumab Use in Patients With Hypereosinophilic Syndromes: A Multicenter Case Series and Review of the Literature(2024)14 cited